Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic
  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Oblong Announces Financial Results for Third Quarter 2022

Oblong, Inc. (Nasdaq: OBLG) (“Oblong” or the “Company”), the award-winning maker of multi-stream collaboration solutions, today reported financial results for the third quarter ending September 30, 2022.

“Our results for the third quarter came in as previously expected and, while our sales and profit results do not yet reflect the strategic and financial actions taken in recent quarters to shift our performance, we are confident in our stated objective to pursue growth both organically and through inorganic means that may include a business combination or sale of the company. Lastly, I want to thank our team for their proven dedication and resilience during this extraordinary and important time for our organization,” commented Pete Holst, President & CEO of Oblong.

  • As of September 30, 2022, the Company had $4.1 million of cash and no debt.
  • Total revenue was $1.2 million for the third quarter of 2022 versus $1.8 million for the third quarter of 2021.
  • Net loss of $7.2 million for the third quarter of 2022, compared to a net loss of $0.7 million for the third quarter of 2021. During the third quarter of 2022, the Company recorded non-cash impairment charges on intangible and other assets of $5.2 million.
  • Adjusted EBITDA (“AEBITDA”) loss of $1.4 million for the third quarter of 2022, compared to an AEBITDA loss of $1.7 million for the third quarter of 2021. AEBITDA loss is a non-GAAP financial measure. See “Non-GAAP Financial Information” below for additional information regarding this non-GAAP financial measure, and “GAAP to Non-GAAP Reconciliation” for a reconciliation of this non-GAAP financial measure to net loss.

Non-GAAP Financial Information

Adjusted EBITDA (“AEBITDA”) loss, a non-GAAP financial measure, is defined as net loss before depreciation and amortization, stock-based compensation and expense, impairment charges, casualty loss, gain on extinguishment of debt, severance, income tax expense, and interest and other (income) expense, net. AEBITDA loss is not intended to replace operating loss, net loss, cash flow or other measures of financial performance reported in accordance with generally accepted accounting principles (GAAP). Rather, AEBITDA loss is an important measure used by management to assess the operating performance of the Company and to compare such performance between periods. AEBITDA loss as defined here may not be comparable to similarly titled measures reported by other companies due to differences in accounting policies. Therefore, AEBITDA loss should be considered in conjunction with net loss and other performance measures prepared in accordance with GAAP, such as operating loss or cash flow used in operating activities, and should not be considered in isolation or as a substitute for GAAP measures, such as net loss, operating loss or any other GAAP measure of liquidity or financial performance. A GAAP to non-GAAP reconciliation of net loss to AEBITDA loss is shown under “GAAP to Non-GAAP Reconciliation” later in this release.

About Oblong, Inc.

Oblong (Nasdaq:OBLG) provides innovative and patented technologies that change the way people work, create, and communicate. Oblong’s flagship product Mezzanine™ is a remote meeting technology platform that offers simultaneous content sharing to achieve situational awareness for both in-room and remote collaborators. Oblong supplies Mezzanine systems to Fortune 500 and enterprise customers. For more information, visit www.oblong.com and Oblong’s Twitter and Facebook pages.

Forward looking and cautionary statements

This press release and any oral statements made regarding the subject of this release contain forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, that address activities that Oblong assumes, plans, expects, believes, intends, projects, estimates or anticipates (and other similar expressions) will, should or may occur in the future are forward-looking statements. Oblong’s actual results may differ materially from its expectations, estimates and projections, and consequently you should not rely on these forward-looking statements as predictions of future events. Without limiting the generality of the foregoing, forward-looking statements contained in this press release include statements relating to (i) the Company exploring strategic alternatives to maximize value for our shareholders and the timing and results thereof, (ii) the Company’s potential future growth and financial performance, and (iii) the success of its products and services. There can be no assurance that the strategic review being undertaken will result in a merger, sale or other business combination involving the Company. The forward-looking statements are based on management’s current belief, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties, including the volatility of market price for our securities, that may cause actual results in future periods to differ materially from such statements. A list and description of these and other risk factors can be found in the Company’s Annual Report on Form 10-K for the year ending December 31, 2021 and in other filings made by the Company with the SEC from time to time. Any of these factors could cause Oblong’s actual results and plans to differ materially from those in the forward-looking statements. Therefore, the Company can give no assurance that its future results will be as estimated. The Company does not intend to, and disclaims any obligation to, correct, update, or revise any information contained herein.

OBLONG, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

($ in thousands)

 

September 30, 2022

 

December 31, 2021

 

(Unaudited)

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash

$

4,143

 

 

$

8,939

 

Restricted cash

 

 

 

 

61

 

Accounts receivable, net

 

357

 

 

 

849

 

Inventory

 

1,027

 

 

 

1,821

 

Prepaid expenses and other current assets

 

868

 

 

 

1,081

 

Total current assets

 

6,395

 

 

 

12,751

 

Property and equipment, net

 

25

 

 

 

159

 

Goodwill

 

 

 

 

7,367

 

Intangibles, net

 

690

 

 

 

7,562

 

Right-of-use assets, net

 

201

 

 

 

659

 

Other assets

 

53

 

 

 

109

 

Total assets

$

7,364

 

 

$

28,607

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

 

401

 

 

 

259

 

Accrued expenses and other current liabilities

 

1,088

 

 

 

959

 

Current portion of deferred revenue

 

571

 

 

 

783

 

Current portion of operating lease liabilities

 

306

 

 

 

492

 

Total current liabilities

 

2,366

 

 

 

2,493

 

Long-term liabilities:

 

 

 

Operating lease liabilities, net of current portion

 

43

 

 

 

236

 

Deferred revenue, net of current portion

 

152

 

 

 

381

 

Total long-term liabilities

 

195

 

 

 

617

 

Total liabilities

 

2,561

 

 

 

3,110

 

Commitments and contingencies

 

 

 

Stockholders’ equity:

 

 

 

Common stock, $.0001 par value; 150,000,000 shares authorized; 30,929,331 shares issued and 30,816,048 outstanding at September 30, 2022 and December 31, 2021

 

3

 

 

 

3

 

Treasury stock, 113,283 shares of common stock at September 30, 2022 and December 31, 2021

 

(181

)

 

 

(181

)

Additional paid-in capital

 

227,611

 

 

 

227,581

 

Accumulated deficit

 

(222,630

)

 

 

(201,906

)

Total stockholders' equity

 

4,803

 

 

 

25,497

 

Total liabilities and stockholders’ equity

$

7,364

 

 

$

28,607

 

OBLONG, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

($ in thousands) (Unaudited)

 

Three Months Ended

 

Nine Months Ended

 

September 30,

 

September 30,

 

 

2022

 

 

 

2021

 

 

2022

 

 

2021

 

Revenue

$

1,185

 

 

$

1,799

 

 

4,050

 

 

5,766

 

Cost of revenue (exclusive of depreciation and amortization and casualty loss)

 

841

 

 

 

1,228

 

 

2,800

 

 

3,767

 

Gross profit

 

344

 

 

 

571

 

 

1,250

 

 

1,999

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

232

 

 

 

693

 

 

1,634

 

 

1,984

 

Sales and marketing

 

282

 

 

 

438

 

 

1,161

 

 

1,537

 

General and administrative

 

1,229

 

 

 

1,628

 

 

4,104

 

 

5,078

 

Impairment charges

 

5,169

 

 

 

254

 

 

12,715

 

 

302

 

Casualty loss

 

 

 

 

 

 

533

 

 

 

Depreciation and amortization

 

592

 

 

 

669

 

 

1,818

 

 

2,098

 

Total operating expenses

 

7,504

 

 

 

3,682

 

 

21,965

 

 

10,999

 

Loss from operations

 

(7,160

)

 

 

(3,111

)

 

(20,715

)

 

(9,000

)

Interest and other expense (income), net

 

(5

)

 

 

(2,449

)

 

1

 

 

(2,659

)

Loss before income taxes

 

(7,155

)

 

 

(662

)

 

(20,716

)

 

(6,341

)

Income tax expense (benefit)

 

(3

)

 

 

 

 

8

 

 

 

Net loss

$

(7,152

)

 

$

(662

)

 

(20,724

)

 

(6,341

)

GAAP to Non-GAAP Reconciliation:

 

Three Months Ended

 

Nine Months Ended

 

September 30,

 

September 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Net loss

$

(7,152

)

 

$

(662

)

 

$

(20,724

)

 

$

(6,341

)

Depreciation and amortization

 

592

 

 

 

669

 

 

 

1,818

 

 

 

2,098

 

Interest and other expense (income), net

 

(5

)

 

 

(2,449

)

 

 

1

 

 

 

(2,659

)

Income tax expense (benefit)

 

(3

)

 

 

 

 

 

8

 

 

 

 

Impairment charges

 

5,169

 

 

 

254

 

 

 

12,715

 

 

 

302

 

Severance

 

 

 

 

12

 

 

 

294

 

 

 

23

 

Casualty loss

 

 

 

 

 

 

 

533

 

 

 

 

Stock-based expense

 

31

 

 

 

502

 

 

 

30

 

 

 

925

 

Adjusted EBITDA Loss

$

(1,368

)

 

$

(1,674

)

 

$

(5,325

)

 

$

(5,652

)

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.